Literature DB >> 6415725

The effects of chronic morphine treatment on neurotensin-induced antinociception.

D Luttinger, S K Burgess, C B Nemeroff, A J Prange.   

Abstract

Previous studies have shown that the opioid antagonist naloxone does not alter neurotensin (NT)-induced antinociception. In the present studies, tolerance to morphine in mice significantly attenuated NT-induced antinociception, but not NT-induced hypothermia. In addition, centrally administered NT inhibited naloxone-precipitated jumping in morphine-dependent mice. These results indicate complex interactions between NT-induced antinociception and opioid systems.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6415725     DOI： 10.1007/BF00439265

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


  15 in total

1.  Neurotensin administered intracisternally inhibits responsiveness of mice to noxious stimuli.

Authors:  B V Clineschmidt; J C McGuffin
Journal:  Eur J Pharmacol       Date:  1977-12-15       Impact factor: 4.432

Review 2.  Narcotic analgestics: CNS sites and mechanisms of action as revealed by intracerebral injection techniques.

Authors:  T L Yaksh; T A Rudy
Journal:  Pain       Date:  1978-04       Impact factor: 6.961

3.  Thyrotropin releasing hormone antagonizes beta endorphin hypothermia and catalepsy.

Authors:  J W Holaday; L F Tseng; H H Loh; C H Li
Journal:  Life Sci       Date:  1978-05-01       Impact factor: 5.037

4.  Inhibition of spinal cord interneurons by narcotic microinjection and focal electrical stimulation in the periaqueductal central gray matter.

Authors:  G J Bennett; D J Mayer
Journal:  Brain Res       Date:  1979-08-24       Impact factor: 3.252

5.  Simultaneous quantitative assessment of morphine tolerance and physical dependence.

Authors:  E L Way; H H Loh; F H Shen
Journal:  J Pharmacol Exp Ther       Date:  1969-05       Impact factor: 4.030

6.  Morphine addiction and withdrawal alters brain peptide concentrations.

Authors:  J E Morley; T Yamada; J H Walsh; C B Lamers; H Wong; A Shulkes; D A Damassa; J Gordon; H E Carlson; J M Hershman
Journal:  Life Sci       Date:  1980-06-30       Impact factor: 5.037

7.  Alterations in nociception and body temperature after intracisternal administration of neurotensin, beta-endorphin, other endogenous peptides, and morphine.

Authors:  C B Nemeroff; A J Osbahr; P J Manberg; G N Ervin; A J Prange
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

8.  Characterization of radioimmunoassayable neurotensin in the rat. Its differential distribution in the central nervous system, small intestine, and stomach.

Authors:  R Carraway; S E Leeman
Journal:  J Biol Chem       Date:  1976-11-25       Impact factor: 5.157

9.  Modification of the actions of ethanol by centrally active peptides.

Authors:  G D Frye; D Luttinger; C B Nemeroff; R A Vogel; A J Prange; G R Breese
Journal:  Peptides       Date:  1981       Impact factor: 3.750

10.  The effects of thyrotropin-releasing hormone on the central nervous system responses to chronic morphine administration.

Authors:  H N Bhargava
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530
View more
  2 in total

1.  Altered morphine-induced analgesia in neurotensin type 1 receptor null mice.

Authors:  G Roussy; H Beaudry; M Lafrance; K Belleville; N Beaudet; K Wada; L Gendron; P Sarret
Journal:  Neuroscience       Date:  2010-08-18       Impact factor: 3.590

2.  Diverse roles of neurotensin agonists in the central nervous system.

Authors:  Mona Boules; Zhimin Li; Kristin Smith; Paul Fredrickson; Elliott Richelson
Journal:  Front Endocrinol (Lausanne)       Date:  2013-03-22       Impact factor: 5.555
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.